复合益生菌对非酒精性脂肪性肝病的作用及机制研究OA
Study on the effect and mechanism of probiotic complex on non-alcoholic fatty liver disease
目的 评估益生菌对高脂饮食(HFD)诱导的非酒精性脂肪性肝病(NAFLD)的保护作用,并探索基于肠道菌群调控的可能机制.方法 将36只雌性SD大鼠按随机数字表法分为对照组、HFD组、DM9054组、86066组、N1115组和复合益生菌组,每组6只.除对照组外,其他5组使用HFD建立大鼠NAFLD模型.对照组和HFD组使用0.9%氯化钠溶液、各益生菌组使用1 × 1010 CFU/mL鼠李糖乳杆菌DM9054、植物乳杆菌86066、副干酪乳杆菌N1115和复合益生菌灌胃给药,1次/d,持续12周.测定各组大鼠体重、Lee指数、肝指数及血液生化指标;采用油红O染色和苏木精-伊红(HE)染色观察肝组织病理变化,采用qRT-PCR法和蛋白质印迹法检测肝组织Toll样受体4(TLR4)、髓样分化因子88(MyD88)、核因子-κB(NF-κB)的mRNA和蛋白相对表达量;采用16S rRNA测序分析肠道菌群的组成和结构变化.结果 对照组大鼠各项指标均正常,肝组织无脂滴聚集及病理改变.与对照组相比,HFD组大鼠体重、Lee指数、肝指数、血脂水平、炎症因子水平及TLR/NF-κB通路mRNA和蛋白相对表达量显著升高,油红O染色显示肝组织大量红色脂滴聚集,HE染色可见弥漫性脂肪变性、气球样变及炎性浸润.与HFD组相比,各益生菌组上述指标均有不同程度改善;其中复合益生菌组在降低最终体重、肝指数、Lee指数、血脂水平、炎症因子水平及TLR/NF-κB通路mRNA和蛋白相对表达量方面显著优于各单益生菌组(均P<0.05),油红O染色显示脂滴聚集减少最明显,HE染色显示肝细胞结构最接近正常,脂肪变性和炎症浸润最轻.此外,复合益生菌组大鼠肠道菌群中g_Shigella、f_Prevotellaceae、g_Prevotella、f_Verrucomi-crobiaceae、o_Verrucomicrobiales、p_Verrucomicrobia、c_Verrucomicrobiae 和 g_Akkermansia 等菌的相对丰度显著高于 HFD 组(P<0.05).结论 益生菌可降低NAFLD大鼠炎症水平,改善肠道菌群组成,其调控机制可能与TRL4/NF-κB通路有关.
Objective To evaluate the protective effects of probiotics against high-fat diet(HFD)-induced non-alcoholic fatty liver disease(NAFLD)and to explore potential mechanisms involving the regulation of the gut microbiota.Methods Thirty-six female SD rats were divided into control group,HFD group,DM9054 group,86066 group,N1115 group and a composite probiotic group,with six rats in each group,using a random number table.With the exception of the control group,the other five groups were used to establish a rat NAFLD model using an HFD.The control and HFD groups were administered 0.9%sodium chloride solution,whilst the probiotic groups were administered the corresponding bacterial strain of Lactobacillus rhamnosus DM9054,L.plantarum 86066,L.paracasei N1115 and the probiotic complex at a concentration of 1 × 1010 CFU/mL via oral gavage,once daily for 12 weeks.Body weight,Lee index,hepatic index and blood biochemical parameters were recorded for rats in each group;Liver tissue pathological changes were examined using oil red O and haematoxylin-eosin(HE)staining;the relative mRNA and protein expression levels of Toll-like receptor 4(TLR4),myeloid differentiation factor 88(MyD88)and nuclear factor-kappa B(NF-κB)in liver tissue were detected using qRT-PCR and Western blot;16S rRNA sequencing was employed to analyze changes in the composition and structure of the gut microbiota.Results All parameters in the control group of rats were normal,with no accumulation of lipid droplets or pathological changes observed in the liver tissue.Compared with the control group,the HFD group exhibited significant increases in body weight,Lee index,hepatic index,blood lipid levels,inflammatory factors levels and the relative mRNA and protein expression levels of TLR/NF-κB pathway;Oil Red O staining revealed extensive accumulation of red lipid droplets in the liver tissue,whilst HE staining demonstrated diffuse steatosis,ballooning degeneration and inflammatory infiltration.Compared with the HFD group,all probiotic groups showed varying degrees of improvement in the aforementioned parameters;among them,the composite probiotic group was significantly superior to the individual probiotic groups in reducing final body weight,hepatic index,Lee index,blood lipid levels,inflammatory factor levels and the relative mRNA and protein expression levels of TLR/NF-κB pathway(all P<0.05).Oil red O staining revealed the most pronounced reduction in lipid droplet accumulation,whilst HE staining showed that the hepatic cell structure was closest to normal,with the mildest steatosis and inflammatory infiltration.Furthermore,the relative abundances of bacteria such as g_Shigella,f_Prevotellaceae,g_Prevotella,f_Verrucomicrobiaceae,o_Verrucomicrobiales,p_Verrucomicrobia,c_Verrucomicrobiae and g_Akkermansia in the gut microbiota of rats in the composite probiotic group were significantly higher than those in the HFD group(P<0.05).Conclusion Probiotics can reduce inflammation levels in rats with NAFLD and improve the composition of the gut microbiota;the regulatory mechanism may be linked to the TRL4/NF-κB pathway.
邵宏华;朱亮;王群星
321000 金华市中心医院药学部321000 金华市中心医院中药房321000 金华市中心医院药学部
非酒精性脂肪性肝病益生菌肠道菌群Toll样受体4/核因子-κB通路
Non-alcoholic fatty liver diseaseProbioticsGut microbiotaToll-like receptor 4/nuclear factor-kappa B pathway
《浙江医学》 2026 (9)
902-907,913,后插1-后插2,9
金华市科技计划项目(2023-4-075)
评论